Showing results (1811-1820 of 1,823) with videos related to

Sort By:
Pageof 183
Cell|August 10, 2019
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer OutcomesErick Riquelme, Yu Zhang, Liangliang Zhang, et al.
The Lancet. Oncology|May 19, 2015
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsJoe Y Chang, Suresh Senan, Marinus A Paul, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
Blood Advances|August 21, 2023
Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphomaRaphael E Steiner, Steven R Hwang, Arushi Khurana, et al.
Blood|February 3, 2021
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphomaPaolo Strati, Sairah Ahmed, Fateeha Furqan, et al.
Blood Advances|August 22, 2020
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphomaPaolo Strati, Loretta J Nastoupil, Jason Westin, et al.
Military Medical Research|January 4, 2026
Artificial intelligence in digital pathology diagnosis and analysis: technologies, challenges, and future prospectsXiu-Ming Zhang, Tian-Hong Gao, Qiu-Yu Cai, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|January 10, 2019
A Cross-National Analysis of the Psychometric Properties of the Geriatric Anxiety InventoryHelge Molde, Inger Hilde Nordhus, Torbjørn Torsheim, et al.
The Lancet. Oncology|January 25, 2022
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trialMichael L Wang, Preetesh Jain, Shuangtao Zhao, et al.
Journal of Neurology|November 28, 2021
Population-attributable fractions of risk factors for all-cause dementia in China rural and urban areas: a cross-sectional studyFei-Fei Hu, Gui-Rong Cheng, Dan Liu, et al.
Pageof 183